Tata India Pharma & HealthCare Fund Regular-IDCW
Tata India Pharma & HealthCare Fund Regular-IDCW: Mutual Fund Overview
Tata India Pharma & HealthCare Fund Regular-IDCW is an Sectoral-Pharma mutual fund with over 10.24 years of performance history. The scheme manages an AUM of ₹1300.81 Cr and has a NAV of ₹27.9707. It is rated '3' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of -3.18%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return -3.18% at 24 Mar 2026 03:59 PM
Fund Details
NAV 27.9707
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount ₹100.0
Fund Age(Year) 10.24
Fund Size(in Crores) 1300.81
Fund Performance
1 Month -6.71%
3 Month -7.72%
6 Month -9.34%
1 Year -3.18%
3 Year 21.51%
5 Year 14.23%
Know This Fund
As on 24 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (97.56%) Market Cap Small Cap 36.93 Mid Cap 28.29 Large Cap 32.34 Top Sectors Healthcare 94.23 Chemicals 3.33 Top Holding Global Health 1.5 Lupin 3.08 Dr. Reddy's Laboratories 3.04 Fortis Healthcare 3.27 Sun Pharmaceutical Industries 9.66 Jubilant Pharmova 0.07 Alkem Laboratories 2.15 Healthcare Global Enterprises 5.04 Cipla 4.55 Ipca Laboratories 0 Bayer CropScience 3.33 CORONA Remedies 0.99 Metropolis Healthcare 3.13 Glaxosmithkline Pharma 1.82 Divi's Laboratories 5.94 Vijaya Diagnostic Centre 1.55 Rainbow Children's 3.83 Dr. Lal Pathlabs 2.71 Abbott India 5.6 Krishna Institute 2.64 Dr. Agarwal's Health Care 0.07 Mankind Pharma 3.4 Syngene International 2.39 Max Healthcare Institute 6.78 Sai Life Sciences 3.25 Laxmi Dental 0.02 Torrent Pharmaceuticals 1.07 Neuland Laboratories 2 FDC 1.82 JB Chemicals 3.21 Sanofi India 1.99 Ajanta Pharma 2.06 Hikal 0.6 Apollo Hospitals Enterprise 5
Debt & Others (2.44%) Sector Allocation Repo 0.2 Cash/Net Current Assets 2.24 Debt Credit Ratings Debt Category Others 2.44
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.89% Ret 1Y -2.44% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -5.25% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.14%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Meeta Shetty
Education Ms. Shetty is Bachelor in Economics and CFA Charterholder
Experience Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
Rajat Srivastava
Education Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 24
Date of Incorporation 2015-12-28
Total AUM 232819.21
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
Tata India Pharma & HealthCare Fund Regular-IDCW FAQs
How to invest in Tata India Pharma & HealthCare Fund Regular-IDCW?
Investing in Tata India Pharma & HealthCare Fund Regular-IDCW through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for Tata India Pharma & HealthCare Fund Regular-IDCW in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of Tata India Pharma & HealthCare Fund Regular-IDCW?
The term expense ratio for Tata India Pharma & HealthCare Fund Regular-IDCW or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of Tata India Pharma & HealthCare Fund Regular-IDCW is 2.14% as of 24 Mar 2026.
What is the NAV of Tata India Pharma & HealthCare Fund Regular-IDCW?
The NAV of Tata India Pharma & HealthCare Fund Regular-IDCW is ₹27.9707 as of 24 Mar 2026.
What is the AUM of Tata India Pharma & HealthCare Fund Regular-IDCW?
The AUM (Assets Under Management) of Tata India Pharma & HealthCare Fund Regular-IDCW is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of Tata India Pharma & HealthCare Fund Regular-IDCW is ₹1300.81 Cr as of 24 Mar 2026.
What is the PE and PB ratio of Tata India Pharma & HealthCare Fund Regular-IDCW?
The PE ratio of Tata India Pharma & HealthCare Fund Regular-IDCW shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in Tata India Pharma & HealthCare Fund Regular-IDCW?
Yes, you can invest in Tata India Pharma & HealthCare Fund Regular-IDCW through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of Tata India Pharma & HealthCare Fund Regular-IDCW in the last 5 years?
The return of Tata India Pharma & HealthCare Fund Regular-IDCW in the last 5 years is 14.23%.
What is the minimum SIP investment required in Tata India Pharma & HealthCare Fund Regular-IDCW?
The minimum SIP investment in Tata India Pharma & HealthCare Fund Regular-IDCW depends on the fund's scheme rules and usually starts at a small amount. For Tata India Pharma & HealthCare Fund Regular-IDCW, the minimum SIP amount is ₹100.0.
What is the current NAV of Tata India Pharma & HealthCare Fund Regular-IDCW?
The NAV of Tata India Pharma & HealthCare Fund Regular-IDCW, as of 24 Mar 2026, is ₹27.9707.
Who manages the Tata India Pharma & HealthCare Fund Regular-IDCW?
The fund managers responsible for Tata India Pharma & HealthCare Fund Regular-IDCW are:
- Meeta Shetty
- Rajat Srivastava